Merck to Hold First-Quarter 2013 Sales and Earnings Conference Call on May 1
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
will hold its first-quarter 2013 sales and earnings conference call with
institutional investors and analysts at 8:00 a.m. EDT on Wednesday, May
1. During the call, Kenneth C. Frazier, chairman and chief executive
officer; Peter N. Kellogg, executive vice president and chief financial
officer; and Adam H. Schechter, president, Global Human Health, will
provide an overvie...
Source: Merck.com - Corporate News - April 1, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news
Mistrial Declared in FOSAMAX® (alendronate sodium) New Jersey State Court Trial
Dateline City:
WHITEHOUSE STATION, N.J.
Merck, known outside the United States and Canada as MSD, today said a mistrial was declared by Judge Carol E. Higbee of the Superior Court for Atlantic County, N.J., in the Su v. Merck case.
One week after opening statements were given, the plaintiff suffered a serious health complication unrelated to her use of FOSAMAX.
Language:
English
Ticker Slug:
Ticker: MRK Exchange: NYSE ...
Source: Merck.com - Corporate News - March 18, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: Corporate News Source Type: news
Statement on FOSAMAX® (alendronate sodium) Product Liability Trial
Dateline City:
WHITEHOUSE STATION, N.J.
Merck, known as MSD outside the United States and Canada, will vigorously defend itself in a jury trial set to begin today in the Superior Court of New Jersey in Atlantic County. InSu v.
Language:
English
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more (Source: Merck.com - Corporate News)
Source: Merck.com - Corporate News - March 11, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: Corporate News Source Type: news
Merck to Present at the 33rd Annual Cowen Health Care Conference
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that Peter N. Kellogg, executive vice president and
chief financial officer, Merck, is scheduled to present at the
33rd Annual Cowen Health Care Conference in Boston on March 6 at 10:40
a.m. EST. Investors, analysts, members of the media and the general
public are invited to listen to a live audio webcast of the presentation
at http://www.merck.com/inves...
Source: Merck.com - Corporate News - March 5, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Latest News Source Type: news
Bruce Kuhlik and Merck Honored by PBI for Commitment to Pro Bono
Dateline City:
WHITEHOUSE STATION, N.J. and WASHINGTON, D.C.
Merck, known as MSD outside the United States and Canada, today announced that the Pro Bono Institute (PBI) has selected Executive Vice President and General Counsel Bruce Kuhlik and the company’s legal department as the winner of the 2013 Laurie D. Zelon Pro Bono Award for their outstanding commitment to pro bono service.
Language:
English
Ticker Slug:
Ticker: MRK Ex...
Source: Merck.com - Corporate News - February 28, 2013 Category: Pharmaceuticals Authors: Maria.tortoreto at merck.com Tags: Bruce Kuhlik Merck PBI pro bono Corporate News Corporate Responsibility News Source Type: news
Merck Announces Second-Quarter 2013 Dividend
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, today
announced that the Board of Directors has declared a quarterly dividend
of $0.43 per share on the company’s common stock for the second quarter
of 2013. Payment will be made on Apr. 5, 2013, to stockholders of record
at the close of business on Mar. 15, 2013.
About Merck
Language:
English
Conta...
Source: Merck.com - Corporate News - February 26, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news
Merck to Present at the Citi 2013 Global Healthcare Conference
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that Peter N. Kellogg, executive vice president and
chief financial officer, Merck, is scheduled to present at the Citi 2013
Global Healthcare Conference in New York on February 27 at 9:35 a.m.
EST. Investors, analysts, members of the media and the general public
are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/...
Source: Merck.com - Corporate News - February 26, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news
Merck and Samsung Bioepis Enter Biosimilars Development and Commercialization Agreement
Dateline City:
WHITEHOUSE STATION, N.J. & SEOUL, South Korea
WHITEHOUSE STATION, N.J. & SEOUL, South Korea--(BUSINESS WIRE)--Merck, (NYSE: MRK) known as MSD outside the United States and Canada,
and Samsung Bioepis Co., Ltd., entered into an agreement to develop and
commercialize multiple pre-specified and undisclosed biosimilar
candidates.
Language:
English
Contact HTML:
Merck Media Relati...
Source: Merck.com - Corporate News - February 20, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Source Type: news
Merck Resolves Securities Class-Action Lawsuits Related to the ENHANCE Trial
Dateline City:
WHITEHOUSE STATION, N.J.
The Company Records $493 Million Charge Reducing 2012 GAAP Results
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, announced
today that it has reached an agreement in principle with plaintiffs to
resolve two federal securities class-action lawsuits. The suits are
pending in the U.S. District Court for the District of New Jersey
against Merck, Schering-Plough Corporation and ...
Source: Merck.com - Corporate News - February 14, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Source Type: news
Merck Statement on Venezuelan Currency Devaluation
Dateline City:
WHITEHOUSE STATION, N.J.
Merck Confirms 2013 Full-Year Guidance and Provides Guidance on First Quarter
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the United States and Canada, said today
that it has completed a preliminary assessment of the impact of the
Venezuelan government’s intention to devalue its currency effective Feb.
13, 2013.
Language:
English
...
Source: Merck.com - Corporate News - February 13, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news
Merck to Present at the Leerink Swann 2013 Global Healthcare Conference
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that Peter N. Kellogg, executive vice president and
chief financial officer, Merck, is scheduled to present at the Leerink
Swann 2013 Global Healthcare Conference in New York on February 13 at
11:30 a.m. EST. Investors, analysts, members of the media and the
general public are invited to listen to a live audio webcast of the
presentation at http://www.mer...
Source: Merck.com - Corporate News - February 12, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news
Merck Announces Full-Year and Fourth-Quarter 2012 Financial Results
Dateline City:
WHITEHOUSE STATION, N.J.
2012 Full-Year Non-GAAP EPS of $3.82, Excluding Certain Items; GAAP EPS of $2.16; Fourth-Quarter Non-GAAP EPS of $0.83, Excluding Certain Items; GAAP EPS of $0.46
2012 Full-Year Worldwide Sales Were $47.3 Billion, a Decrease of 2 Percent, Including a 3 Percent Unfavorable Impact from Foreign Exchange; Fourth-Quarter Worldwide Sales Were $11.7 Billion, a Decline of 5 Percent, Including a 2 Percent Unfavorable Impact...
Source: Merck.com - Corporate News - February 1, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news
Merck to Present at the 31st Annual J.P. Morgan Healthcare Conference
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that Kenneth C. Frazier, Merck's chairman and chief
executive officer, is scheduled to present at the 31st Annual
J.P. Morgan Healthcare Conference in San Francisco on January 7 at 4:00
p.m. PST (7:00 p.m. EST).
Language:
English
Contact HTML:
...
Source: Merck.com - Corporate News - January 4, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Source Type: news
Merck to Present at 2013 Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
announced today that Kenneth C. Frazier, Merck's chairman and chief
executive officer, is scheduled to present at the Goldman Sachs
Healthcare CEOs Unscripted: A View from the Top meeting in New York City
on Thursday, Jan. 3 at 8:45 a.m. EST.
Language:
English
Contact HTML:
...
Source: Merck.com - Corporate News - January 2, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Source Type: news
Merck Announces Fourth-Quarter 2012 Sales and Earnings Conference Call
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada,
will hold its fourth-quarter 2012 sales and earnings conference call
with institutional investors and analysts at 8:00 a.m. EST on Friday,
Feb. 1. During the call, Kenneth C. Frazier, chairman and chief
executive officer; Peter N. Kellogg, executive vice president and chief
financial officer; and Adam H.
Language:
English ...
Source: Merck.com - Corporate News - January 2, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Source Type: news
